Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime ...

Current guidelines support culprit-only PCI in these cases, but the “hypothesis-generating” results suggest taking a closer ...

SGMC Health has successfully performed its first procedure using the Abiomed Impella 5.5 with SmartAssist, a minimally ...

The syndrome of cardiogenic shock has been defined as the inability of the heart -- as a result of impairment of its pumping function -- to deliver sufficient blood flow to the tissues to meet ...

WASHINGTON, DC—Early-stage cardiogenic shock leads to poor outcomes but is underrecognized, with only one in four affected patients having any indication in their electronic medical record (EMR) that ...

For circulatory support in cardiogenic shock, the best choice between Impella and intra-aortic balloon pump (IABP) has been controversial. Now, new data is complicating the debate. Presenting at ...

Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...

In patients with heart failure, cannabis use disorder was linked to higher odds of MI, cardiogenic shock and arrhythmias. Mortality and respiratory failure were lower among cannabis users.

Cardiogenic shock is a medically urgent condition and drug treatment innovation is desired by providers who treat the conditionWARRINGTON, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, ...

Clinical examination—encompassing both patient interview and physical inspection—has long served as one of the most essential ...

For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the ...